University of Wisconsin-Madison researchers have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as well in the body as they do in the lab, the nanoparticles ...
Bio & Medicine
Jan 29, 2020
0
376
New cancer immunotherapies involve extracting a patient's T cells and genetically engineering them so they will recognize and attack tumors. This technique is a true medical breakthrough, with an increasing number of leukemia ...
Bio & Medicine
Jan 29, 2020
1
84
One day the advance could lead to a patient's own skin cells being used to produce new cells for cancer immunotherapy or to test autoimmune disease interventions.
Cell & Microbiology
Jan 8, 2020
0
625
St. Jude Children's Research Hospital scientists have identified a new therapeutic strategy that enhanced cancer immunotherapy, slowed tumor growth and extended the lives of mice with cancer. The research appears today in ...
Cell & Microbiology
Dec 12, 2019
0
370
Of the many marvels of the human immune system, the processing of antigens by the class I proteins of the major histocompatability complex (MHC-I) is among the most mind-boggling. Exactly how these proteins carry out their ...
Cell & Microbiology
Dec 3, 2019
0
116
A team of researchers from the Harbin Institute of Technology and Peking University has used single-particle cryogenic electron microscopy to study the human T cell receptor complex. In their paper published in the journal ...
The idea of genetically modifying a patient's own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells ...
Biotechnology
Jul 11, 2019
0
29
Researchers from ETH Zurich demonstrate that genetically identical cells exhibit differing responses in their motility towards chemical attractants. Average values hide the full picture when it comes to describing the behavior ...
Evolution
Apr 24, 2019
0
303
In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells. ...
Materials Science
Apr 18, 2019
1
646
In 1989, two undergraduate students at the Free University of Brussels were asked to test frozen blood serum from camels, and stumbled on a previously unknown kind of antibody. It was a miniaturized version of a human antibody, ...
Bio & Medicine
Apr 11, 2019
0
1381
